ADAMIS PHARMACEUTICALS CORP (ADMP)
Institutional ownership reported to the SEC as of Q1 2023, across 18 quarters.
37
Reporting holders
$3.1M
Reported value
0.2%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 37 | $3.1M | 27,037,986 | 4 | 6 | 4 | 0.2% |
| Q4 2022 | 36 | $1.9M | 10,923,732 | 10 | 4 | 5 | 3.3% |
| Q3 2022 | 39 | $2.6M | 12,853,454 | 4 | 3 | 7 | 2.8% |
| Q2 2022 | 44 | $6.7M | 12,860,143 | 4 | 7 | 8 | 3.4% |
| Q1 2022 | 44 | $7.6M | 12,920,734 | 2 | 6 | 13 | 3.5% |
| Q4 2021 | 51 | $9.7M | 14,656,525 | 6 | 12 | 6 | 8.7% |
| Q3 2021 | 54 | $16.0M | 15,061,394 | 8 | 12 | 9 | 8.5% |
| Q2 2021 | 51 | $18.8M | 16,166,836 | 10 | 19 | 4 | 5.5% |
| Q1 2021 | 53 | $13.0M | 12,530,347 | 20 | 10 | 6 | 9.5% |
| Q4 2020 | 36 | $2.9M | 6,056,705 | 2 | 9 | 5 | 0.3% |
| Q3 2020 | 45 | $5.2M | 6,625,469 | 11 | 6 | 9 | 0.8% |
| Q2 2020 | 43 | $2.7M | 5,098,363 | 8 | 7 | 6 | 0.0% |
| Q1 2020 | 43 | $5.8M | 11,585,536 | 10 | 5 | 4 | 0.0% |
| Q4 2019 | 37 | $3.8M | 5,441,723 | 5 | 8 | 9 | 0.0% |
| Q3 2019 | 47 | $6.4M | 9,034,772 | 8 | 10 | 11 | 0.2% |
| Q2 2019 | 50 | $10.5M | 7,687,726 | 7 | 11 | 11 | 4.4% |
| Q1 2019 | 57 | $23.3M | 10,424,101 | 10 | 12 | 14 | 2.2% |
| Q4 2018 | 57 | $20.2M | 8,645,624 | 2 | 1 | 0 | 3.5% |